Company Filing History:
1 out of 64 
1 out of 101 Years Active: 2017
Title: Raruch Brenner: Innovator in Gastric Cancer Prognosis
Introduction
Raruch Brenner is a notable inventor based in Hod Hashron, Israel. He has made significant contributions to the field of medical research, particularly in the prognosis of gastric cancer. His innovative work has the potential to improve survival predictions for patients undergoing surgical operations.
Latest Patents
Raruch Brenner holds a patent for "Compositions and methods for prognosis of gastric cancer." This patent describes compositions and methods that aid in survival prediction for gastric cancer patients post-surgery. The compositions include microRNA molecules that are associated with the prognosis of gastric cancer, along with various nucleic acid molecules related to or derived from these microRNAs. He has 1 patent to his name.
Career Highlights
Throughout his career, Raruch Brenner has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Rosetta Genomics Ltd. and Mor Research Applications Ltd. His work in these organizations has contributed to advancements in cancer research and treatment methodologies.
Collaborations
Raruch Brenner has collaborated with various professionals in his field, including Moshe Hoshen. These collaborations have fostered innovation and have been instrumental in the development of new technologies and methods in cancer prognosis.
Conclusion
Raruch Brenner's contributions to the field of gastric cancer prognosis highlight his role as an innovator in medical research. His patent and collaborations reflect his commitment to improving patient outcomes through scientific advancements.